Ardsley Advisory Partners’s Astera Labs ALAB Stock Holding History

Ardsley Advisory Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,500	Closed	-$1.24M	–	192
2024 Q2	$1.24M	Buy	+20,500	New	+$1.42M	0.18%	92

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Ardsley Advisory Partners's ALAB Position: Q3 2024 in Review

Ardsley Advisory Partners sold out of Astera Labs (ALAB) in Q3 2024, closing a stake of 20,500 shares — an estimated $1.24M sold.

Ardsley Advisory Partners first reported a position in ALAB in Q2 2024 and held it in 1 quarter. The position peaked at $1.24M in Q2 2024. 245 funds tracked by Wall St. Rank hold ALAB as of Q3 2024.

Ardsley Advisory Partners reported no remaining Astera Labs position as of Q3 2024 after selling out during the quarter.
Ardsley Advisory Partners sold 20,500 Astera Labs shares in Q3 2024, an estimated $1.24M.
Ardsley Advisory Partners first reported a position in Astera Labs in Q2 2024 and held it in 1 quarter.
Ardsley Advisory Partners's Astera Labs position peaked at $1.24M in Q2 2024.
245 funds tracked by Wall St. Rank held Astera Labs as of Q3 2024.

Based on Ardsley Advisory Partners's 13F filing for Q3 2024, filed 14 Nov 2024.